SUMMARY Since the hypotensive and natrluretic role recently attributed to dopamine (DA) is difficult to test (free DA is usually undetectable in plasma) we measured free and conjugated DA by a newly developed method of hydrolysis of conjugated catecholamlnes in four pheochromocytoma, four primary aldosteronism and 34 essential hypertensive patients subjected to selective venous catheterization or peripheral venous sampling. The 16 control subjects had plasma DA of 0.98 ± 0.1 ng/ml (SE), almost 100% of which was conjugated, and a urinary excretion of 2 ± 03 fig/min of DA, 79% of which was conjugated.
D OPAMINE (DA) has been suggested to be an important neurotransmitter not only in the central nervous system but also in the peripheral autonomic nervous system. 1 Peripheral dopaminergic antihypertensive mechanisms have been postulated on the basis of the pharmacological action of DA, such as renal and mesenteric vasodilatation, natriuresis, 2 decrease of blood pressure 8 and the presence of specific DA receptors in the vascular bed and kidney. 4 Additional evidence was obtained from the hypotensive action of the dopaminergic effects caused by apomorphine 8 or bromoergocriptine' and the aldosterone-suppressing effect of the latter. 7 Other possible sites of the hypotensive action of DA include its ability to inhibit ganglionic cholinergic transmission, 8 its presynaptic inhibition of norepinephrine (NE) release 9 and its dilatation of specific areas of the venous capacitance bed. 10 There is, however, only limited evidence for the role of endogenous dopaminergic mechanisms in blood pressure regulation such as a proposed dopaminergic vasodilatory response caused by hypothalamic stimulation 11 or the finding that the free urinary DA excretion, relative to urinary free NE, is lower in essential hypertensive patients than in control subjects. 11 One of the main difficulties in evaluating the role of endogenous DA in hypertension is the fact that free DA in plasma is normally undetectable or just above FIGURE 
Free (open area) and conjugated plasma dopamine (DA) (hatched area) in 12 nonpheochromocytoma patients, in three patients with predominantly norepinephrine-producing pheochromocytoma (middle columns
and in one with a predominantly epinephrine-and DA-producing pheochromocytoma (right columns) at several sites of venous sampling described in the upper part of the figure. Asterisks = significant differences. detection limits. 1 ' A new method of hydrolysis of conjugated catecholamines 14 permitted us to demonstrate that this is due to the fact that almost 100% of plasma DA is conjugated in contrast to only 80% conjugation for NE and epinephrine (E). Thus, the free plasma NE + E determined by conventional methods represents only 20% of the total NE + E. Thjs fraction of circulating NE and E is believed to best reflect the sympathetic nervous activity." The measurement of the conjugated fraction of NE + E may be of additional value since conjugated plasma NE + E in essential hypertension was found to be positively correlated with mean arterial pressure and age" to which free NE is also known to be positively correlated. 17 In the case of plasma DA, since free DA is usually below detection limits, measurement of conjugated DA becomes the only alternative; the rationale of the measurement of conjugated DA is supported by the observation that free DA released at the only site measurable in vivo, that is, the adrenal venous outflow, 18 is rapidly conjugated and circulates as DA sulfate. 1 ' This study reports a new approach to the exploration of the biological role of DA in hypertension, namely the measurement of free and conjugated plasma and urinary DA in three forms of human hypertension: pheochromocytoma, primary aldosteronism and essential hypertension.
Methods

Venous Cattaeterization Studies
Sixteen hypertensive patients, 10 men and six women, were examined for hypertension of adrenal origin by venous catheterization. Fourteen were investigated for a pheochromocytoma because of typical hypertensive paroxysms and/or elevated excretion of vanillylmandelic acid (VMA), urinary free catecholamines or a positive glucagon test. In two patients adrenal venous catheterization was performed prior to adrenal phlebography to identify an aldosterone-producing adenoma and catecholamines were determined in parallel with aldosterone. All patients had not been receiving hypotensive medication for at least 5 days and were fasting for 12 hours before the study. Catheterization was performed under visual control via the femoral vein aided by a small volume of injected contrast substance (Hypaque, M 75%). Alpha-adrenergic blocking agents were not given routinely but were prepared on a stand-by basis in case of a paroxysm. Blood (10 ml) was drawn into DA IN PHEOCHROMOCYTOMA, ALQOSTERONISM AND EH/ Kuchel et al. cooled plastic vials (containing 0.5 mg/ml of sodium metabisulfite as antioxidant) from the following sites: superior vena cava, suprarenal portion (below the ostium of the hepatic veins) of the inferior vena cava, left or right adrenal veins, infrarenal inferior vena cava and sometimes both renal veins.
In the final evaluation, four of 16 patients were shown to have an adrenal pheochromocytoma and surgical removal was successful in all cases. The adrenocortical adenomas were removed in the two patients with primary aldosteronism. The remaining 10 patients were shown to suffer from labile essential hypertension that resembled pheochromocytoma.
Peripheral Venous and Urinary Sampling
Twenty-four patients (12 men, 12 women) suffering from hypertension (mean age 42 years) were thoroughly investigated to exclude any form of secondary hypertension. Routine examination, ECG, rapid sequence I.V. pyelogram, BUN and plasma creatinine levels were normal in all patients. When renovascular hypertension and pheochromocytoma were suspected, arteriography and urinary VMA and catecholamine excretions eliminated this possibility. In all patients drug treatment of hypertension had ceased for at least 1 week; longer acting drugs, such as rauwolfia, guanethidine or a-methyldopa, had been stopped at least J month before the study.
Three of four patients with primary aldosteronism had an adrenal adenoma removed and subsequently improved; one patient with micronodular hyperplasia did not improve following unilateral adrenalectomy. The four pheochromocytoma patients investigated by venous catheterization had also peripheral venous sampling while their blood pressure was normal; in one patient samples were obtained during three consecutive spontaneous, but mostly normotensive, atypical paroxysms. Sixteen control subjects (eight men, eight women, mean age 29 years) who had no family history of hypertension, normal blood pressure and normal routine examination were studied for comparison.
The hypertensive and control subjects fasted overnight and on the morning of the test spent at least 2 hours lying down, without smoking. Control experiments 20 have shown that the effects of food ingestion on conjugated plasma DA are relatively shortlived and can be disregarded in subjects who have fasted for at least 12 hours before sampling. Saline was infused intravenously for at least 20 minutes before blood was drawn at 8:30 a.m. Twelver or 24-hour urine collections were obtained for DA determination and the results are expressed in ^g/min. In patients with pheochromocytoma, plasma for catecholamines was sampled either after 12 hours fasting or during the spontaneous paroxysm, which always occurred at least 4 hours after the last meal, at various times of the day or night.
The samples of peripheral blood and that obtained by catheterization were kept on ice and centrifuged within 5 minutes at 4000 g X 15 minutes at 4°C. The plasma was frozen and stored at -80°C until analysis. Plasma was deproteinized with 3 N perchloric acid containing 1% ethyleneglycol-bis (/3-amino-ethyl ether)-N,N-tetraacetic acid (EGTA) so that the final acid concentration was 0.3 N. In our hands deproteinization with 0.3 N perchloric acid did not release free DA from the conjugated pool. Conjugated DA was hydrolyzed by lyophilization of the deproteinized plasma solution as previously described.
14 Dopamine was determined in duplicate samples by a radioenzymatic assay of Coyle and Henry 11 using S-adenosyl-L-methionine ('H methyl) as a methyl donor. The limit of detection is 20 pg for DA, which is equivalent to 53 pg/ml of plasma. The separation of NE and E was performed by thin layer chromatography as described by Da Prada and Zilrcher." Separation of DA from NE was not affected by high concentrations of NE + E relative to DA. The interassay coefficient of correlation of the method for DA with the fluorometric method 23 was 0.97 (p < 0.001). The data were analyzed either by Student's t test or, when more than two groups were compared, by the multiple range test of Newman and Keuls as modified for unequal group size by Steel and Torrie." Results are expressed as means ± SE.
Results
Patients with Pheochromocytoma
Even during the normotensive periods, four patients with pheochromocytoma had elevated VMA (mean 34 ± 13 vs 12.4 ± 2.4 mg/24 hrs in 10 essential hypertensive patients), urinary free NE + E (534 ± 79 vs 259 ± 57.4 Mg/24 hrs) and in one patient a particularly high free E excretion (388 and 493 vs 49 ± 1 Mg/24 hrs). That same patient also had a high urinary free DA excretion (1010 vs 495 ± 123 n/24 hrs). Three out of four patients with adrenal medullary tumors appeared to produce predominantly NE and E but one patient had an alternating E and DA hypersecretion. The regional venous DA content in 12 non-pheochromocytoma hypertensive patients, three pheochromocytoma patients producing predominantly NE and E, and one patient with the DA-and E-producing tumor is illustrated in figure 1 . At two inferior vena cava sites of sampling, the predominantly NE-producing pheochromocytoma had a higher mean conjugated DA but free DA was not elevated when compared to other hypertensive patients. This finding was even more evident when all sites of sampling, except adrenal vein, were combined (mean 6.05 ± 0.5 vs 2.45 ± 0.3, p < 0.001). The DA-and E-secreting pheochromocytoma had an enormous release of free and conjugated DA in the adrenal vein draining the tumor with a 30% content of free DA (compared to 10-15% in other hypertensive and pheochromocytoma patients). Free DA in the suprarenal inferior vena cava was twice that observed in its infrarenal portion. In the superior vena cava, DA was already more than 95% conjugated. The most dramatic changes in plasma catecholamines were seen in this patient in three consecutive spontaneous crises (fig. 2) crisis was accompanied by an outpouring of exclusively free E with predominantly £-type symptoms and signs. The second crisis was accompanied by less E and more free NE release, resulting in a predominantly a-type of response. The third crisis resulted in an outpouring of free DA associated with polyuria, possibly a combination of /3-adrenergic and dopaminergic response and rather low blood pressure. We were unable to document other similar normotensive paroxysms but the absence of the a-component in this particular crisis may be due to the fact that the patient started to receive phenoxybenzamine (10 mg on the preceding day). The other patients with pheochromocytoma did not have detectable peripheral free DA during hypertensive crises but had an elevated conjugated plasma DA of the same order as found in the regional venous outflow measurements.
Patients with Primary Aldosteronism
Patients with primary aldosteronism had elevated free and conjugated plasma DA and increased urinary excretion of total DA as compared to control subjects ( fig. 3 ). After removal of the adenoma, disappearance of the hyperaldosteronism and hypertension was associated with a decrease in urinary DA (free and conjugated when measured) to normal values in two adenoma patients but remained elevated in another patient with micronodular bilateral adrenal hyperplasia in whom a unilateral adrenalectomy did not affect the hyperaldosteronism and hypertension (fig. 4) . In one patient with primary aldosteronism studied by venous catheterization, the left adrenal venous outflow of total DA was more than twice as high as in the peripheral venous plasma (6.64 vs 2.53 ng/ml); in another patient with primary aldosteronism, catheterization of the left adrenal vein was unsuccessful but there was a gradient of total DA concentrations between the infrarenal and suprarenal portion of the inferior vena cava (1.38 vs 1.84 ng/ml) and between the right and left renal vein (0.88 vs 1.25 ng/ml). This suggested an adrenal contribution to the total plasma DA in primary aldosteronism; the left adrenal vein usually drains into the left renal vein, thus concentration differences between the right renal vein are due to the adrenal outflow.
Patients with Essential Hypertension
Patients with essential hypertension had an elevated mean total plasma DA in samples of peripheral blood when compared to control subjects ( fig. 3) . This difference was not due to the slightly lower age of the control group since it persisted in 11 pairs of agematched control and essential hypertensive subjects (p < 0.05). There was no correlation between conjugated plasma DA and age or mean arterial pressure in either the normotensive or the hypertensive group. During the regional catheterization ( fig. 1 ) in hypertensive patients without pheochromocytoma, the mean adrenal outflow of total DA (14% of it free) was approximately double that observed in the infrarenal inferior vena cava, which was 100% conjugated. The urinary excretion of free and total urinary DA was lower in essential hypertension than in patients with primary aldosteronism (fig. 3 ).
Discussion
Measurement of free and conjugated DA in human hypertension offers a new method of exploration of the role of this enigmatic catecholamine in hypertension. Free DA in plasma remains below detection limits in most hypertensive patients as well as in control subjects in both the infrarenal inferior vena cava and superior vena cava. The adrenal outflow of free DA explains the presence of some free DA in the suprarenal inferior vena cava. The adrenal medulla was previously shown to contain DA in man 25 but this was attributed to its precursor role. Although free DA release from the adrenal gland has been demonstrated in the dog," this study reports the first demonstration of release of free DA without pharmacological stimulation in man. Dopamine in the adrenal outflow is largely conjugated and the 14% free DA disappears as the adrenal outflow mixes with the inferior vena cava stream. Epinephrine and norepinephrine, in contrast, leave the adrenal gland almost entirely in free form and in concentrations up to 50 times higher than in the infrarenal inferior vena cava, creating a free NE + E gradient between the infra-and suprarenal inferior vena cava. 18 The inability to detect free DA in human plasma has been observed by other authors using the method of Coyle and Henry. 21 The presence Pheochromocytoma is a condition in which there is autonomous release of catecholamines. In three out of four pheochromocytoma patients, free NE was the main catecholamine flooding the circulation at the height of the paroxysm, which returned to the normal ratio of free to conjugated NE following decrease of blood pressure." No free plasma DA could be found during either of these paroxysms. The pheochromocytoma in the patient with alternating E and DA release could be easily missed because of occasionally normotensive paroxysms. Louis and coworkers 27 previously described a dopa-and DAsecreting pheochromocytoma. A high DA secretion has been suggested to be associated with tumor malignancy." In our case the regional free and conjugated DA measured for the first time in such a patient indicates that a high degree of free DA outflow from the tumor can create such a gradient in free DA concentrations between the infrarenal and suprarenal inferior vena cava that even peripheral blood can be flooded by free DA. The type of the crisis with predominance of either alpha, beta or dopaminergic response depends on the predominance of the free portion of either of the three catecholamines in the circulation. The predominantly DA-secreting pheochromocytoma" has to be suspected as the cause of the normotensive crises in which DA counteracts the vasoconstrictor effect of NE and produces, probably via a dopaminergic receptor-mediated visceral and renal vasodilatation, hypotension and polyuria.
The source of the elevated conjugated plasma DA in the NE-producing pheochromocytoma is difficult to establish. The fact that DA conjugates are elevated at all sites of sampling except the adrenal outflow may indicate an increased extra-adrenal generation of conjugated DA in pheochromocytoma (induction of conjugating enzymes?) or a decrease of the renal clearance of conjugated DA. In the rare case of DA secretion (because of a deficiency of dopamine-/9-hydroxylase in the tumor?™) diffusion of free DA, a mechanism that would be in contrast to the exocytosis observed on other nerve terminals,* 0 may become a dominant feature and result in a massive release of free DA. The free DA becomes rapidly conjugated as indicated by the finding that while the inferior vena cava DA is exclusively free, DA in the superior vena cava becomes over 95% conjugated.
In contrast to pheochromocytoma, the increased plasma and urinary free and conjugated DA in primary aldosteronism is probably not autonomous but of homeostatic nature. This is suggested by its reversibility when the source of hyperaldosteronism is removed. In contrast, the patient with bilateral adrenal hyperplasia had a persistently high urinary DA excretion and the hyperaldosteronism was not influenced by removal of one adrenal gland. The catheterization data, although limited, suggest an adrenal medullary origin of this increased DA. In view of the relationship between urinary sodium and free DA excretion and the suggested natriuretic role of free endogenous DA 81> " it is conceivable that the "escape" from the sodium retaining action of the massive hyperaldosteronism is due, at least in part, to an increase of dopamine. This contrasts to the "failure to escape," sodium retention and edema in patients with secondary hyperaldosteronism and low urinary free DA excretion."
The elevated conjugated DA in essential hypertension, in contrast to the lower urinary free and conjugated DA, when compared to primary aldosteronism, is difficult to explain. An increased adrenal medullary DA release is suggested by the adrenal vein outflow data. Such an involvement is in accordance with other studies implicating adrenal medullary hyperfunction in hypertension on the basis of elevated plasma epinephrine." On the other hand, the lower excretion of free urinary DA in the presence of an increased circulating pool of conjugated DA points to an abnormality in the excretory mechanism of DA by the kidney. Recent data" indicate that renal excretory mechanisms for DA involve conjugation and deconjugation, both enzymatic steps in which genetic factors can also be operating. It is not clear to what degree the low urinary free DA excretion relates to a defect of (dopamine-modulated?) sodium excretion in essential hypertension," in contrast to the excellent, even exaggerated natriuresis in primary aldosteronism 17 in which there is high urinary free DA excretion.
It remains to be seen exactly how conjugated DA mirrors the biologically active components of the peripheral dopaminergic system and how the system of conjugating and deconjugating enzymes is integrated into the overall mechanisms that determine the biological activity of DA. This activity probably represents the other side of the balance within the dual sympathoadrenal system in which DA opposes the vasoconstriction induced by NE and sodium retaining action of NE and aldosterone.
